Gao Hanlin 4

4 · Fulgent Genetics, Inc. · Filed May 28, 2026

AI-generated summary of this filing

Updated May 28, 2026

Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 945 Shares

What Happened

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 945 shares on May 27, 2026. The sales generated approximately $16,632 based on a weighted-average price of $17.60 per share. The filing lists the transaction as an open‑market/private sale (code S) and indicates the sale was to satisfy tax withholding obligations related to vested restricted stock units (RSUs).

Key Details

Transaction date: 2026-05-27; Form 4 filed: 2026-05-28 (timely filing).
Prices: multiple transactions at $17.39–$17.76; reported weighted-average sale price $17.60.
Total proceeds reported: $16,632 (945 shares).
Reason: Footnote states shares were sold to satisfy tax withholding on RSUs granted 2024-02-26.
Footnote also notes sales occurred in multiple transactions and the filer can provide detailed per‑trade breakdowns upon request.
Shares owned after the transaction: not specified in the provided filing.

Context

This was a sale tied to tax withholding for vested RSUs (routine administrative sale), not necessarily a discretionary market sale expressing sentiment. Sales to cover taxes are common following vesting events and typically do not indicate a change in an insider’s view of the company.

Form 4

Period: 2026-05-27

Chief Scientific Officer

Transactions

Footnotes (2)

[F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
[F2]The shares were sold in multiple transactions at prices ranging from $17.39 to $17.76, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Signature

/s/ Paul Kim as Attorney-in-Fact|2026-05-28

1 file